Premier Research Group appoints new chief executive
This article was originally published in SRA
Executive Summary
UK-based pharmaceutical and medical device contract research organisation Premier Research Group has appointed Ludo Reynders as its new chief executive. Dr Reynders was previously chief executive of AAIPharma, overseeing that firm's transition from a specialty pharmaceutical company to a full-service drug development services company. Dr Reynders worked at Quintiles prior to joining AAIPharma, holding positions such as managing director of PharmaBio evelopment and chief executive of Quintiles Development Services.
You may also be interested in...
Pharma Guidelines, ending 1 July 2011
Recently updated and newly issued documents
EuropaBio appoints new chairman
EuropaBio, the European biotech industry association, has appointed Stephan Tanda as its new association chair. Mr Tanda, a member of the managing board of life sciences and materials sciences firm DSM, succeeds GlaxoSmithKline's Andrea Rappagliosi, who will remain a member of the EuropaBio board.
Medtech Guidelines, ending 24 June 2011
Recently updated and newly issued documents